• Profile

Lipid accumulation product is a powerful tool to predict non-alcoholic fatty liver disease in Chinese adults

Nutrition & Metabolism Aug 09, 2017

Dai H, et al. – Lipid accumulation product (LAP) was tested for its accuracy as an effective screening tool for diagnosing non-alcoholic fatty liver disease (NAFLD) in the general population. Findings demonstrated a significant association of LAP with the presence and severity of NAFLD. Furthermore, for the detection of NAFLD in the general population, LAP showed a high diagnostic accuracy. Data reported that the diagnostic accuracy of LAP was especially high among younger age groups.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen